Putrescine, spermidine and spermine are organic cations implicated in learning, memory consolidation, reconsolidation and neurogenesis. These physiological processes are closely related, and convincing evidence indicates that neurogenesis is implicated both, in the establishment and maintenance of remote contextual fear memory. Although brain-derived neurotrophic factor (BDNF) is a key mediator involved in both neurogenesis and memory consolidation, effects of spermidine on persistence of memory after reactivation (reconsolidation) and possible involvement of BDNF have not been investigated. Here, we investigated whether the intrahippocampal infusion of spermidine improves the persistence of reconsolidated contextual fear conditioning memory in rats and whether these possible changes depend on BDNF/ TrkB signaling in the hippocampus. The infusion of spermidine immediately and 12 h post-reactivation improved fear memory of the animals tested seven but not two days after reactivation. The facilitatory effect of spermidine on the persistence of reconsolidated memory was blocked by the TrkB inhibitor ANA-12 (73.6 pmol/site) and accompanied by mature BDNF level increase in the hippocampus, indicating that it depends on the BDNF/TrkB pathway. We also investigated whether spermidine alters BDNF levels and neural progenitor cell differentiation in vitro. Spermidine increased BDNF levels in vitro, facilitating neuritogenesis and neural migration. Spermidine-induced neuritogenesis in vitro was also blocked by ANA-12 (10 mM). Since spermidine increases BDNF levels and facilitates neural differentiation in vitro, similar mechanisms may be involved in spermidine-induced facilitation of the persistence of reconsolidated memory.
Introduction
Polyamines, putrescine, spermidine (SPD) and spermine (SPM) are ubiquitous organic cations implicated in multiple physiological processes, including neuroprotection, cell proliferation, neural differentiation, learning and memory (Guerra, Rubin, & Mello, 2016; Malaterre et al., 2004; Schreiber, Boeshore, & Laube, 2004; Skatchkov, Woodbury-fariña, & Eaton, 2014) . In fact, accumulating evidence suggests that polyamines may improve learning/memory by modulating GluN2B subunit of NMDA receptor (Mony, Zhu, Carvalho, & Paoletti, 2011) . Accordingly, polyamines, particularly SPD, improve memory at different stages of memory formation/-consolidation including: acquisition (Berlese et al., 2005; Camera, Mello, Ceretta, & Rubin, 2007; ) , early (Berlese et al., 2005; Guerra et al., 2011 Guerra et al., , 2012 and late consolidation (Signor, Mello, Porto, Ribeiro & Rubin, 2014; Signor, Temp, Mello, & Rubin, 2016) , extinction (Gomes et al., 2010) and reconsolidation (Ribeiro, Signor, Mello, & Rubin, 2013 ; for a comprehensive review see Guerra et al., 2016) .
Brief reexposure to the conditioned stimulus (unreinforced retrieval) results in labilization of the memory trace (Sara, 2000) and, depending on the conditions prevailing at that moment, it may strengthen or update the reactivated memory engram (Nader, Schafe, & Ledoux, 2000) , a process that has been termed reconsolidation (Sara, 2000) . While different neurochemical mechanisms have been implicated in memory reconsolidation, there are only a few studies that have investigated effects of pharmacological manipulation on the persistence of reconsolidated memories. In fact, infusion of anisomycin after fear memory reactivation attenuhttp://dx.doi.org/10.1016/j.nlm.2017.02.013 1074-7427/Ó 2017 Elsevier Inc. All rights reserved.
ates the persistence of a reconsolidated memory in a time-and reactivation-dependent manner (Nakayama, Yamasaki, & Yuji, 2016) .
Current evidence indicates that SPD improves memory reconsolidation by a mechanism that involves calcium-dependent protein kinase and protein synthesis in rats (Girardi et al., 2016) and NR2B-NMDARs are involved in memory destabilization that entails early and late Arc expression (Nakayama et al., 2016) . In this context, adult hippocampal neurogenesis has been implicated in several forms of hippocampus-dependent learning and memory (Aimone, Deng, & Gage, 2010) , including long-term retention in the Morris Water Maze (Deng, Saxe, Gallina, & Gage, 2009; Jessberger et al., 2009 ) and persistence of memories in shockmotivated aversive tasks (Pan, Storn, & Xia, 2012; Pan, Strom & Xia, 2013) . Indeed, neurogenesis is required to update stored object recognition memory and new neurons are selectively recruited to hippocampal circuits during the update of stored information (Pereira & Carrión, 2015) . In this context, previous works have demonstrated that SPD treatment induces differentiation of PC12 cells, evidenced by neurite outgrowth (Schreiber et al., 2004) , and promotes axon elongation of hippocampal mature neurons in vitro (Chu, Saito, & Abe, 1994) . In addition, polyamine depletion decreases cell proliferation in dentate gyrus and subventricular zone, suggesting that polyamines promote neurogenesis (Malaterre et al., 2004) . However, a specific role of SPD on differentiation and neurite elongation of non-cancer stem cells is yet to be determined.
Brain-derived neurotrophic factor (BDNF) is a protein widely expressed in the mammalian brain that is necessary for synaptic plasticity, neurogenesis, and memory formation in different learning tasks (Hsiao, Hung, Chen, & Gean, 2014; Kang, Welcher, Shelton, & Schuman, 1997; Pang et al., 2004; Patterson et al., 1996; Poo, 2001; Tyler & Pozzo-miller, 2001 ), whose biological actions are mediated by the tropomyosin-related kinase B (TrkB) receptor (Michalski & Fahnestock, 2003) . Accordingly, BDNF increases the number of dendritic spines on apical dendrites of CA1 pyramidal neurons, as well as the number of CA3-CA1 excitatory synapses in hippocampal slice cultures (Bamji, Rico, Kimes, & Reichardt, 2006; Tyler & Pozzo-miller, 2001 ). Current evidence indicates that BDNF induced around 12 h after acquisition initiates a cascade of molecular and cellular events that leads to synaptic remodeling necessary for persistence of LTM storage (Bekinschtein et al., 2007 (Bekinschtein et al., , 2008 . These cellular events triggered by BDNF include enhanced neurite outgrowth, which may result in synaptogenesis associated with learning and memory (Geinisman, et al., 2000; Shors, 2004) . In addition, BDNF is necessary and sufficient to maintain the reactivated fear extinction (Radiske et al., 2015) .
Despite the evidence suggesting a role for polyamines in the persistence and reconsolidation of fear memory, no study has addressed the role of polyamines in the persistence of reconsolidated memory, as well as the involvement of BDNF and neurogenesis in this effect. Therefore, in the current study we investigated whether SPD alters the persistence of reactivated fear memory in rats, whether these possible changes depend on the BDNF/TrkB pathway in the hippocampus. In addition, we investigated whether SPD alters differentiation of neural progenitor cells in vitro through BDNF/TrkB pathway.
Material and methods

Animals
Experimentally naive male Wistar rats (220-280 g) and C57BL/6 mice from the animal house of the Federal University of Santa Maria were used. The animals were housed four to a cage and maintained on a 12 h light/dark cycle (lights on at 7:00 A.M.) at a temperature of 21°C with water and standard laboratory chow (Guabi, Santa Maria, Rio Grande do Sul, Brazil) ad libitum. All experimental procedures were conducted in accordance with the policies on the use of animals and humans in neuroscience research, revised and approved by the Society for Neuroscience Research in January 1995 and with the institutional and national regulations for animal research (process 2340010415).
Surgery
Rats were anaesthetized with an intraperitoneal (i.p.) injection of a mixture of ketamine (80 mg/kg) and xylazine (8 mg/kg) and were implanted with two 27-gauge guide cannulae placed 1 mm above the CA1 region of the dorsal hippocampus at the following coordinates: A = 4 mm; L = 3.0 mm; and V = 2.0 mm (Paxinos & Watson, 1986) . Placement of injections was histologically verified as described elsewhere (Rubin et al., 1997) . Only data from the animals with correct cannulae placement were analyzed (Fig. 1C ).
Drugs
Rats were injected with saline (0.9% NaCl), N-(3-aminopropyl)-1.4-butanediamine trihydrochloride (spermidine; Sigma, St. Louis, MO) or [N2-2-2-Oxoazepan-3-yl amino] carbonyl phenyl benzo (b) thiophene-2-carboxamide] (ANA-12; Sigma, St. Louis, MO). Spermidine solutions were prepared daily in saline (0.9% NaCl). The doses of SPD were selected for in vivo experiments on previous studies of our group , and for in vitro experiments were based on studies of Chu et al. (1994) and Chu, Saito, and Abe (1995) .
In the in vivo experiment injections were performed immediately, 6 h, 12 h or 24 h following bilateral injections into the hippocampus (0.5 ml/brain hemisphere for 1 min). The injections were performed by using an infusion pump using a 30-gauge needle fitted into the guide cannula. The tip of the injection needle protruded 1.0 mm beyond that of the guide cannula into the CA1 region in the dorsal hippocampus. The needles were left in place for additional 60 s to minimize backflow.
Apparatus
Contextual fear training, reactivation and testing took place in an identical observation chamber (30 Â 25 Â 25 cm), located in a well-lit room. The front and ceiling walls of the chamber were made of clear acrylic plastic, whereas the lateral and rear walls were made of opaque plastic. The floor of the chamber consisted of 32 stainless steel rods (3 mm diameter), spaced 1 cm apart and wired to a shock generator. The cage was cleaned with 30% ethyl alcohol before and after each rat occupied it.
Contextual fear conditioning
Each rat was subjected to a single fear-conditioning training session, as described by Rubin et al. (2004) with some modifications. In brief, the rat was placed in the conditioning chamber (conditioned stimulus, CS) and habituated to the apparatus for 3 min. Immediately after habituation, three 1 s, 0.4 mA foot shocks (unconditioned stimulus, US) were delivered. The shocks were 40 s apart. After the last CS/US pairing, rats were allowed to stay in the chamber for additional 60 s before returning to their home cages.
Reactivation and testing sessions
The rats were subjected to reactivation and testing sessions according to Ribeiro et al. (2013) . Briefly, twenty-four hours after conditioning rats were re-exposed to the same conditioning context for 3 min, in the absence of footshock (reactivation session).
The animals were returned to their home cages immediately after the reactivation session.
Two or seven days after reactivation, each rat was placed back in the conditioning chamber and an 8 min test session was performed. During this time, no shock was given, and every 4 s an instantaneous observation of the rat was made to assess whether it was in freezing, or not. Behavior was judged as freezing if there was an absence of any visible movement, except for that required for breathing. The percentage of samples scored as freezing during this 8 min was taken as a contextual fear conditioning measure.
Isolation, culture, and differentiation of NPCs
Neural Progenitor Cells (NPCs) were obtained from embryo telencephalons (embryonic day 13.5) of C57BL/6 mice. The animals were sacrificed in a CO 2 gas chamber. Telencephalons were dissected and incubated with trypsin for 5 min at 37°C. After that, samples were plated at a density of 2 Â 10 5 cells/ml in culture medium DMEM/Ham's F-12 medium containing 2% B-27 (Life Technologies, Carlsbad, California), epidermal growth factor (EGF) and fibroblast growth factor-2 (FGF2) (both at 20 ng/ml, SigmaAldrich, St-Louis, MO), and antibiotics (100 units/ml penicillin and 100 lg/ml streptomycin) and cultured at 37°C in a watersaturated atmosphere and 5% of CO 2 (Pillat et al., 2015; Reynolds & Weiss, 1996) . For neural differentiation, neurospheres were plated onto adherent poly-L-lysine-and laminin-precoated cell culture grade dishes and cultured in the presence of 2% B-27 (Life Technologies) and saline or 10 nM SPD. The medium and theses treatments were replaced every other day for 7 days.
Migration and neuritogenesis of NPCs
Migration was evaluated on day 1 of differentiation as the distance of the foremost cells to the neurosphere boundary. Cell number and neurite outgrowth assays was quantified as described previously (Kudo et al., 2015) . In brief, the cells were examined using a phase-contrast microscope (DP72; Olympus, Tokyo, Japan). The neurite length was examined at the end of differentiation (day 7) in the absence or presence of the different treatment regimes. For the neurite growth assay, the cell number in the field was counted and cells displaying projections 1.5 times longer than the length of the cell body were considered positive. Each data point corresponds to the counts obtained from three or four independent wells (Kudo et al., 2015) . The neural migration and length of neurite in cells was calculated by the ImageJ program. All experiments were performed in triplicate.
BDNF measurement
Three hours after the infusion of SPD the hippocampi were homogenized (1:10 w/v in lysis buffer: 137 mM NaCl 20 mM Tris-HCl (pH 8.0) 10% glycerol 1 mM PMSF 0.5 mM sodium vanadate and protease and phosphatase inhibitors (Sigma, St. Louis, MO). In vitro-differentiated cells were treated with SPD (10 nM) for 16 h and homogenized at a concentration of 100 ml/2 Â 10 5 -cells. The samples were centrifuged (11,000g, 20 min, 4°C) and the supernatants were collected for mature BDNF quantification by the BDNF Emax Ò Immuno Assay System (Promega) according to the manufacturer procedures. Total BDNF quantification was carried out by regular ELISA in samples treated with acid (1 N HCl, pH 2.5), according to the manufacturer procedures. The optical densities were determined at 450 nm in a microplate reader (Molecular Devices, Sunnyvale, CA). 
Statistical analyses
Data were analyzed by one-way analysis of variance (ANOVA) or Student's t-test depending on the experimental design. Post hoc analyses were carried out by the Bonferroni's test, when indicated. A p < 0.05 was considered significant.
2.11. Experimental groups 2.11.1. Experiment 1
This experiment was designed to investigate whether there is a time window of sensitivity to SPD infusion following memory reactivation on the memory persistence. Rats were trained in the fear conditioning apparatus, as described above. Twenty-four hours after conditioning rats were re-exposed to the same conditioning context for 3 min, in the absence of footshock (reactivation session). Immediately, 6 h, 12 h or 24 h post-reactivation, the animals received an i.h. infusion of vehicle (0.9% NaCl, 0.5 ml/site, i.h.) or SPD (0.02-2 nmol/site), and two or seven days after reactivation (days 4 and 9, respectively) were tested in the fear conditioning apparatus, as described above.
Experiment 2
A control experiment was performed to evaluate whether the improving effect of the injection of SPD 12 h after the reactivation session (36 h post-training) on the persistence of reactivated memory depends on reactivation, and is not due to a SPD injection 36 h after training. Animals were trained in the fear conditioning apparatus, but were not subjected to the memory reactivation session 24 h later. Animals received an i.h. infusion of saline (0.9% NaCl, 0.5 ml/site, i.h.) or SPD (2 nmol/site) following 36 h of training. They were tested in the fear conditioning apparatus on day 9, as described above.
Experiment 3
This experiment was designed to investigate the involvement of the TrkB receptor in the improving effect of SPD on the persistence of reconsolidated memory. Rats were trained in the fear conditioning apparatus, as described above. Twenty-four hours after conditioning rats were re-exposed to the same conditioning context for 3 min, in the absence of footshock (reactivation session). Rats received saline (0.9% NaCl, 0.5 ml/site, i.h.) or ANA-12 (73.6 pmol/ site, i.h.) immediately or 12 h after the reactivation session. Five minutes thereafter the animals were injected with saline or SPD (2 nmol/site), and were tested for memory persistence 7 days later (day 9).
Experiment 4
This experiment was designed to investigate the effect of i.h. infusion of SPD on total and mature BDNF levels. Rats were trained in the fear conditioning apparatus, as described above. Twentyfour hours after conditioning rats were re-exposed to the same conditioning context for 3 min, in the absence of footshock (reactivation session). Twelve hours post-reactivation, the animals received an i.h. infusion of saline (0.9% NaCl, 0.5 ml/site, i.h.) or SPD (2 nmol/site). Three hours after the infusion of SPD the animals were sacrificed and the hippocampi were dissected for ELISA analysis of total and mature BDNF levels.
Experiment 5
This experiment was designed to investigate the effect of SPD on the neural differentiation of NPCs. The doses used in the current experiment are similar to those used in other studies (Chu et al., 1994) . We first performed the migration assay on day 1 of differentiation in the absence (control) or presence of SPD (10 nM). NPCs have a radial migration pattern from the edge of neurospheres, where the region limited by the dotted lines comprised approximately 95% of migrating cells. After that, on day 7 of differentiation, we performed the neurite and BDNF measurements in the absence (control) or presence of SPD (10 nM) according to Sections 2.8 and 2.9. The effect of ANA-12 (10 mM) on SPD-induced neurite outgrowth was also examined on day 7 of differentiation, according to Section 2.8.
Results
Fig . 1A and B shows the effect of bilateral i.h. infusion of SPD (0.02-2 nmol/site) immediately post-reactivation on the memory of fear assessed 2 or 7 days after reactivation, respectively. Statistical analysis (one-way ANOVA) revealed that SPD did not alter freezing scores of animals tested 2 days after reactivation (day 4, Fig. 1A ). On the other hand, 2 nmol/site of SPD increased the freezing scores of animals tested 7 days after reactivation (day 9) [F (3,23) = 5.55, p = 0.005, Fig. 1B ], indicating that SPD injection immediately post-reactivation improves the persistence of reconsolidated memory. Fig. 2A and B shows the effect of bilateral i.h. infusion of SPD (0.02-2 nmol/site) following 6 h of reactivation of fear memory was assessed 2 or 7 days after reactivation, respectively. Statistical analysis (one-way ANOVA) revealed that SPD did not alter the freezing scores of animals tested 2 (day 4, Fig. 2A ) and 7 days (day 9, Fig. 2B ) after reactivation.
Fig . 3A and B shows the effect of bilateral i.h. infusion of SPD (0.02-2 nmol/site) 12 h post-reactivation on the memory of fear assessed 2 or 7 days after reactivation, respectively. Statistical analysis (one-way ANOVA) revealed that SPD did not alter the freezing scores of animals tested 2 days after reactivation (day 4, Fig. 3A ). On the other hand, 2 nmol of SPD increased the freezing scores of animals tested 7 days after reactivation (day 9) [F(3,23) = 5.12, p = 0.007, Fig. 3B ], indicating that SPD injection 12 h postreactivation improves the persistence of reconsolidated memory.
Fig . 4A and B shows the effect of bilateral i.h. infusion of SPD (0.02-2 nmol/site) 24 h post-reactivation on the memory of fear assessed 2 or 7 days after reactivation, respectively. Statistical analysis (one-way ANOVA) revealed that SPD did not alter the freezing scores of animals tested 2 days (day 4, Fig. 4A ) and 7 days (day 9, Fig. 4B ) after reactivation. Fig. 5 reveals the effect of the i.h. infusion of SPD (2 nmol/site) 36 h after training on the persistence of fear conditioning in the absence of reactivation session. Statistical analysis (Student ttest) of freezing scores revealed that SPD did not alter contextual fear conditioning in the absence of reactivation. This control experiment shows that the currently described facilitatory effect of SPD depends on reactivation and, therefore, cannot be attributed to a late effect of the polyamine on memory. Fig. 6A and B respectively demonstrate the effect of the bilateral i.h. infusion of ANA-12 (73.6 pmol/site) immediately or 12 h after reactivation on the improvement of persistence (test at day 9) of reconsolidated memory induced by the infusion of SPD (2 nmol/ site) immediately or 12 h after reactivation. Statistical analysis (two-way ANOVA) revealed a significant interaction among pretreatment (Sal or ANA-12) and treatment (Sal or SPD) [F(1,22) = 5.36, p = 0.030] immediately after reactivation (Fig. 6A ). This result indicates that ANA-12 prevents the improvement of persistence of reconsolidated memory induced by SPD infusion immediately after reactivation. Similarly, a significant interaction among pretreatment (Sal or ANA-12) and treatment (Sal or SPD) 12 h after reactivation [F(1,20) = 4.57, p = 0.045; Fig. 6B ] was found, indicating that ANA-12 also prevents the facilitatory effect of SPD given 12 h after reactivation on the persistence of reconsolidated memory. Fig. 7A and B shows the effect of bilateral i.h. injection of vehicle (saline) or SPD (2 nmol/site) on total and mature BDNF levels. Statistical analysis (Student's t-test) revealed that SPD infusion did not alter total BDNF (Fig. 7A ) but increased mature BDNF levels in the hippocampus [t(10) = 3.03, p = 0.012, Fig. 7B] .
The Supplementary Fig. 1 , demonstrates the representative in vitro formation of neurospheres, migration and differentiation of NPCs. The migration pattern can be visualized in the bottom images on the first day of differentiation, while the progress of differentiation can be visualized by neurite outgrowth along the whole course of differentiation. Since the generation and migration of neurons to where they are needed in the brain is essential for the modification of neural circuitry (Ghashghaei, Lai, & Anton, 2007) , we initially studied whether the SPD alters neural migration during in vitro differentiation. Representative images of the radial migration pattern from the edge of neurospheres in samples treated with saline or 10 nM SPD are shows in Fig. 8A . The area between the white lines comprised approximately 95% of migrating cells. Statistical analysis (Student t-test) revealed that SPD increased neural migration [t(4) = 3.91, p = 0.01, Fig. 8B ] on day 1 of differentiation.
We also investigated whether SPD modulates NPCs differentiation. Therefore, we incubated NPCs on adherent matrix of poly-Llysine and laminin for 7 days in the presence of saline (control) or SPD (10 nM). Neuritogenesis was identified by differential interference contrast microscopy in cells from the second and seventh days of differentiation. Fig. 8C reveals the representative images of cells treated with saline or SPD on day 2 of differentiation. Statistical analysis (Student's t-test) revealed no significant effect of SPD on the number of neurites in the second day of differentiation (Fig. 8D) . However, statistical analysis (two-way ANOVA and Bonferroni's test) revealed that SPD increases the number of neurites at the end of differentiation (day 7; Fig. 8E and F) [F(1,8) = 13.09; p = 0.007], but does not alter its length (Fig. 8G ). These results demonstrate that SPD potentiates neuritogenesis in neural progenitor cells, in agreement with data from PC12 cell line (Schreiber et al., 2004) . Interestingly, this effect occurs in the same time window of the behavioral changes observed in the experiments in vivo.
In an effort to elucidate whether BDNF is necessary for SPDinduced synaptic plasticity, neural differentiation and memory formation (Hsiao et al., 2014; Kang et al., 1997; Pang et al., 2004; Patterson et al., 1996; Poo, 2001; Tyler & Pozzo-miller, 2001 ), we investigated whether SPD regulates BDNF expression in differentiated neural progenitor cells. Statistical analysis (Student's t-test) revealed that SPD up-regulates BDNF levels in cell culture [t(4) = 5.22; p = 0.006, Fig. 8H ]. A further question was whether SPDinduced neuritogenesis involves the BDNF/TrkB pathway. Differential interference contrast microscopy data shown in Fig. 8E and F revealed that ANA-12 (10 mM) prevents SPD-induced neuritogene- 
Discussion
In the current study, we showed that the intrahippocampal infusion of SPD immediately or 12, but not at 6 or 24 h after reactivation increased freezing scores at the testing session carried out 7 days after reactivation (Figs. 1B and 3B ). Memory facilitation did not occur if testing was carried out 2 days after reactivation (Figs. 1A and 3A) . These results indicate that SPD facilitates the persistence of reconsolidated fear memory in a time-dependent manner, suggesting at least two time windows for the modulation of reconsolidation persistence by polyamines (0 and 12 h after reactivation). Moreover, the facilitatory effect of SPD on the persistence of reconsolidated fear memory was prevented by ANA-12, a TrkB antagonist, suggesting the involvement of BDNF in this effect of SPD (Figs. 6A and B) . In line with this view, we found that mature BDNF levels increase in the hippocampus 3 h after SPD infusion, further supporting a role for BDNF in the effects of SPD (Fig. 7B) .
Experiments with neural progenitor cells in vitro showed that SPD facilitates cell migration (Fig. 8B) , increases the number of neurites (Fig. 8F ) and up-regulates BDNF levels (Fig. 8H) 7 days after the addition of SPD to the cell culture medium. The TrkB antagonist ANA-12 prevented SPD-induced neurite outgrowth, further supporting a role for BDNF in neuritogenic effect of this polyamine. This is the first study to demonstrate the involvement of the BDNF/TrkB pathway in the facilitatory effect of SPD on memory and neuritogenesis of neural progenitor cells. Our in vivo findings are, to some extent, in agreement with Katche & Medina, 2015 , who have shown that early pharmacological manipulation of BDNF-mediated responses, even before training, may facilitate memory persistence without affecting longterm memory assessed at 2 days after training. Considering that the persistence of a reconsolidated memory was facilitated by a polyamine and depends on BDNF, one might reason that similar mechanisms may be involved in the persistence of a newly formed memory and of a reconsolidated memory. However, one must also be aware that there is currently limited data supporting this view, and the accumulating literature will show whether this prediction may apply or not.
Current evidence suggests that SPD administration 30 min pretraining, immediately after training or post-reactivation, improves the contextual memory of fear (Berlese et al., 2005; Camera et al., 2007; Girardi et al., 2016; Ribeiro et al., 2013) . On the other hand, the administration of SPD 6 h post-training and 10 min pre-test does not alter the memory of inhibitory avoidance task (Berlese et al., 2005) , suggesting that polyamines play a role only in the early stages of memory consolidation. However, we have recently shown that SPD also improves late consolidation . In fact, intrahippocampal infusion of SPD 12 h posttraining improves fear memory persistence and involves GluN2B-containing NMDA receptors, PKA pathway and protein synthesis in rats . However, no study has so far addressed whether the facilitatory effect of polyamines on memory persistence applies to reconsolidated memories or involves BDNF.
BDNF is a key member of the neurotrophic family of signaling proteins. In addition to its well-documented participation in neuronal proliferation and survival, it regulates synaptic plasticity, neurogenesis, and memory storage (Bekinschtein, Cammarota, & Medina, 2014; Bekinschtein et al., 2008; Panja & Bramham, 2014; Rosas-Vidal, Do-Monte, Sotres-Bayon, & Quirk, 2014) . Late expression of mature BDNF in the amygdala (Ou, Yeh, & Gean, 2010) and hippocampus (Bekinschtein et al., 2007 (Bekinschtein et al., , 2008 (Bekinschtein et al., , 2014 Katche & Medina, 2015) is required for persistence of fear memory. Notwithstanding, the involvement of BDNF in memory reconsolidation has seldom been demonstrated (Giachero, Bustos, Calfa, & Molina, 2013; Samartgis, Schachte, Hazi, & Crowe, 2012; Wang et al., 2012) . Indeed, it has been suggested that BDNF participates in memory consolidation but not in reconsolidation (Lee, Everitt, & Thomas, 2004; Lee & Hynds, 2013) . However, a recent study has shown increases in pro-BDNF and BDNF levels as well as TrkB phosphorylation in the persistence of extinction of a reactivated fear memory (Radiske et al., 2015) . Moreover, a role for BDNF in the reconsolidation of fear memory has been proposed in humans (Asthana et al., 2016) .
Memory reconsolidation is the direct effect of memory reactivation followed by stabilization of newly synthesized proteins (Sara, 2000) . It is fairly known that neural encoding of both newly and reactivated memories requires synaptic plasticity. In fact, it is widely accepted that BDNF facilitates synaptic plasticity and stimulates neuronal differentiation and that neurogenesis is an underlying process to memory consolidation (Hsiao et al., 2014; OrtegaMartinez, 2015; Pang et al., 2004) . In this regard, in the current study we showed that the intrahippocampal infusion of SPD does not alter total BDNF levels ( Fig. 7A ), but significantly increases mature BDNF (Fig. 7B ) levels in the hippocampus. Interestingly, proBDNF elicits apoptosis via activation of p75(NTR), Rac-GTPase, JNK, and caspase-3, while mature BDNF signals cell survival via activation of TrkB, ERKs and Akt, and deactivation of caspase-3 (Koshimizu, Hazama, Hara, Ogura, & Kojima, 2010) . Moreover, tissue plasminogen activator (tPA), by activating the extracellular protease plasmin, converts the precursor proBDNF to the mature BDNF (mBDNF), and such conversion is critical for LTP expression in mouse hippocampus (Pang et al., 2004) . Therefore, it is possible that SPD does not induce BDNF production, but its conversion to the mature and more active form.
Exogenous polyamines promote neuritogenesis, neurite outgrowth and regeneration of cultured rat hippocampal neurons (Abe, Chida, Nishiyama, & Saito, 1993; Chu et al., 1994; Malaterre et al., 2004 ). In the current study, we showed that SPD increases number of neurites (Fig. 8F) , facilitates cell migration (Fig. 8B) , and induces up-regulation of BDNF levels (Fig. 8H) , seven days after the addition of SPD to the cell culture medium. In this context, BDNF also modifies the structure of nearby dendrites, increases the number of CA3-CA1 excitatory synapses in hippocampal culture and regulates axonal branching and refinement of synapses (Bamji et al., 2006; Tyler & Pozzo-Miller, 2001 . Therefore, it is reasonable to propose that SPD-induced BDNF increase (or maturation) may induce neurogenesis (demonstrated in vitro) and, by these means, improve persistence of reactivated fear memory.
In summary, this study provides experimental evidence for a role of hippocampal polyamines in the persistence of a reconsolidated fear memory. SPD facilitated cell migration, increased neurite number and BDNF levels in neural progenitor cells and expression of mature BDNF levels in hippocampus of adult rats. While the experimental approaches used in this study do not permit to conclude that SPD-induced improvement in memory depend on hippocampal neurogenesis, they are sufficient to propose a role for SPD in the persistence of reconsolidated fear memory and neurogenesis mediated by BDNF/TrkB pathway. 
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Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.nlm.2017.02.013. Fig. 8 . Effects of spermidine on migration and differentiation of NPCs. Phase contrast images representing radial migration pattern after 1 days of neural differentiation in the presence or absence of spermidine (10 nM; A). Spermidine increased the neural migration (B). Phase contrast images showing neuritogenesis after 2 (C) and 7 days (E) of neural differentiation. Scale = 50 lm. Spermidine did not alter the number of neurites on 2 day (D), but it altered on 7 day and TrkB antagonist ANA-12 (10 mM) reversed this effect (F). Spermidine did not alter the lenght of neurites on 7 day (G). Spermine increased the BDNF levels in differentiated cells (day 7) (H). Data are expressed as mean + S.E. M., * p < 0.05 compared with control (Saline/Saline) group, # < 0.01 compared with ANA-12-Saline group, @ <0.05 compared with ANA-12/spermidine group.
